Active Motif Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Active Motif Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011795
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, epigenetics and chromatin; antibodies and protein detection and quantitation; and others. Active Motif caters to academic and government institutions, biotechnology and pharmaceutical companies, hospitals and reference laboratories. The company operates in the US, Japan, Belgium, and China. Active Motif is headquartered in Carlsbad, California, the US.

Active Motif Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Active Motif Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Active Motif Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Active Motif Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Active Motif Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Active Motif Inc, Medical Devices Deals, 2011 to YTD 2017 9
Active Motif Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Active Motif Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Forge Therapeutics Enters into Research Agreement with Active Motif 11
ChemPartner Enters into Co-Development Agreement with Active Motif 12
Center for Biotech Enters Into Co-Development Agreement With Active Motif 13
Acquisition 14
Active Motif Acquires SwitchGear Genomics, Provider Of Gene Regulation Products 14
Active Motif Inc – Key Competitors 15
Active Motif Inc – Key Employees 16
Active Motif Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Active Motif Inc, Pharmaceuticals & Healthcare, Key Facts 2
Active Motif Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Active Motif Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Active Motif Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Active Motif Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Active Motif Inc, Medical Devices Deals, 2011 to YTD 2017 9
Active Motif Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Forge Therapeutics Enters into Research Agreement with Active Motif 11
ChemPartner Enters into Co-Development Agreement with Active Motif 12
Center for Biotech Enters Into Co-Development Agreement With Active Motif 13
Active Motif Acquires SwitchGear Genomics, Provider Of Gene Regulation Products 14
Active Motif Inc, Key Competitors 15
Active Motif Inc, Key Employees 16
Active Motif Inc, Other Locations 17
Active Motif Inc, Subsidiaries 17

★海外企業調査レポート[Active Motif Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gable Holdings Inc:企業の戦略・SWOT・財務分析
    SummaryGable Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Crosstex International, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Crosstex International, Inc. (Crosstex), a subsidiary of Cantel Medical Corp. is a medical device company that manufactures infection prevention and control products. The company provides treatment accessories, surface disinfectants, personal barriers, environmental barriers, cleaning soluti …
  • Regal Petroleum plc (RPT)(石油・ガス分野):企業M&A動向
    Summary Regal Petroleum plc (Regal) is an oil and gas company. The company explores, develops and produces oil and natural gas. It owns and operates Mekhediviska - Golotovschinska and Svyrydivske gas and condensate fields in north-eastern Ukraine. Regal sells its gas, condensate and LPG production t …
  • Suven Life Sciences Ltd. (SUVEN)(製薬・医療分野):企業M&A動向
    Summary Suven Life Sciences Ltd (Suven) is a biopharmaceutical company. The company designs, manufactures and supplies API's, advanced intermediates, and fine chemicals for the life science industry. Its API's include aripiprazole, calcium acetate, divalproex sodium, entacapone, fenoprofen calcium, …
  • Dennis Publishing, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dennis Publishing, Ltd. Mergers …
  • STWA, Inc. (ZERO):企業概要、財務及び戦略的SWOT分析
    Summary STWA, Inc. (STWA), also known as Save The World Air, Inc. is an oil and gas company. The company operates through its business segment, namely, Upstream Producers, Midstream Transporters and Downstream Refiners. It designs and manufactures production models and tests devices and promotes cru …
  • Sidi Kerir Petrochemicals Co. (SKPC):企業の財務及び戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co. (Sidpec) is a chemical company that manufactures and sells petrochemical products. The company offers high density and linear low density polyethylene, which are used in film industry, blow moulding, injection moulding, roto moulding; butene-1 and ethylene. It o …
  • Shinsei Bank, Limited (8303):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Shinsei Bank, Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Senex Energy Limited (SXY)(石油・ガス分野):企業M&A動向
    Summary Senex Energy Limited (Senex) formerly Victoria Petroleum N.L., is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets in Australia. Senex holds a diversified portfolio of oil and gas assets in Australia’s Cooper, Eromanga a …
  • DSW Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "DSW Inc. : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, …
  • CorVel Corporation (CRVL):企業財務及び戦略的SWOT分析
    Summary CorVel Corporation (CorVel) is a risk management solution provider that offers technology services. The company provides communication and information technology to improve healthcare management for workers’ compensation, group health, auto and liability claims management. It offers service, …
  • Costco Wholesale Corporation (COST):企業の財務・戦略的SWOT分析
    Costco Wholesale Corporation (COST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pinetree Capital, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pinetree Capital, Ltd. Mergers …
  • Korian SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Korian SA Mergers and Acquisiti …
  • United Technologies Corporation:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on United Technologies Corporation providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the …
  • Ocean Rig UDW, Inc. (ORIG)(石油・ガス分野):企業M&A動向
    Summary Ocean Rig UDW, Inc. (Ocean Rig) is a drilling service provider. The company provides oilfield services for offshore oil and gas exploration, development and production drilling. It specializes in drilling services in ultra deep water and harsh environment. Ocean Rig operates a fleet consisti …
  • Protea Biosciences Group Inc (PRGB):企業財務及び戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops technology for the identification, characterization, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic applications. The company’s products include prote …
  • Portlogic Systems Inc. (PGSY):企業概要、財務及び戦略的SWOT分析
    Summary Portlogic Systems Inc. (Portlogic) is a mobile and internet software solution provider. The company provides licensing of portal software products and custom software programming services. It offers portal software product such as online administration interface and provides functionality, a …
  • Lotus Pharmaceutical Co., Ltd. (1795):企業の財務及び戦略的SWOT分析
    Summary Lotus Pharmaceutical Co., Ltd. (Lotus) is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of cardiology, rheumatology, cancer, woman healthcare, oncology, dyslipidemia, hypertension, auto immune, nephrolog …
  • AstraZeneca Plc (AZN):企業のM&A・提携動向(医療機器分野)
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and can …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆